Skip to Content

Par C210 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint Par C210 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Par Pharmaceutical Companies, Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Par C210

Fenofibric acid delayed-release 135 mg Par C210

Fenofibric Acid Delayed-Release

Par C210
135 mg
Blue & Yellow
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Companies, Inc.

Labelers / Repackagers

NDC Code Labeler / Repackager
10370-0210 Anchen Pharmaceuticals, Inc.
68084-0715 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.